Vitamin D Receptor Bsm I Polymorphism and Osteoporosis Risk: A Meta-Analysis from 26 Studies

Authors:

Abstract
Objective: Growing evidence has shown that vitamin D deficiency can cause lower bone mineral density (BMD) and an increased risk of osteoporosis. Vitamin D receptor ( VDR ) Bsm I polymorphism (rs1544410) can affect BMD variation and circulating osteocalcin levels. To date, a wide range of epidemiological studies have been carried out to evaluate the association between VDR Bsm I polymorphism and susceptibility to osteoporosis. Conflicting results, however, were obtained. The aim of this study was to evaluate the effect of VDR Bsm I polymorphism on osteoporosis risk using a meta-analysis. Methods: Twenty-six publications were identified by searching PubMed and Embase databases. The association between VDR Bsm I polymorphism and osteoporosis was estimated by calculating pooled odds ratios (ORs) with corresponding 95% confidence intervals (CIs). Results: The bb genotype was associated with a significantly decreased risk of osteoporosis in overall comparison (bb vs. BB: OR=0.61, 95% CI, 0.40-0.92; bb vs. BB/Bb: OR=0.70, 95% CI, 0.52-0.95, respectively). Subgroup analyses showed that the bb genotype had a decreased risk of developing osteoporosis in postmenopausal women (bb vs. BB/Bb: OR=0.68, 95% CI, 0.46-0.98) and Africans (Bb/bb vs. BB: OR=0.18, 95% CI, 0.09-0.37). Conclusion: The VDR Bsm I polymorphism may have a protective role against the development of osteoporosis.

This publication has 41 references indexed in Scilit: